1414524-11-0

Basic information

• Product Name: N-(4-methoxybenzyl)benzo[4,5]thieno[3,2-d]pyrimidin-4-amine
• Synonyms: N-(4-methoxybenzyl)benzo[4,5]thieno[3,2-d]pyrimidin-4-amine
• CAS NO: 1414524-11-0
• Molecular Weight: 321.403
• Mol File: 1414524-11-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-(4-methoxybenzyl)benzo[4,5]thieno[3,2-d]pyrimidin-4-amine(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-methoxybenzyl)benzo[4,5]thieno[3,2-d]pyrimidin-4-amine(1414524-11-0)
• EPA Substance Registry System: N-(4-methoxybenzyl)benzo[4,5]thieno[3,2-d]pyrimidin-4-amine(1414524-11-0)

Safety Data

• Hazardous Substances Data: 1414524-11-0(Hazardous Substances Data)

Upstream product

• 36822-09-0 4-chloro-3,4-dihydrobenzo[4,5]thiophene[3,2-d]pyrimidine 
• 2393-23-9 4-methoxy-benzylamine 
• 36822-08-9 <1>benzothieno<3,2-d>pyrimidin-4(3H)-one 
• 35212-85-2 3-Amino-benzo[b]thiophene-2-carboxylic acid methyl ester 

Relevant articles and documents

Synthesis and evaluation of apoptosis induction of thienopyrimidine compounds on KRAS and BRAF mutated colorectal cancer cell lines

Monoclonal antibodies (MoAb) and tyrosine kinase inhibitors (TKI) targeting the EGFR (Epidermal Growth Factor Receptor) pathways are currently used in colorectal cancer treatment. Despite the improvement of median overall survival, resistance is observed